Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Revenue (2020 - 2025)

PROCEPT BioRobotics has reported Revenue over the past 6 years, most recently at $76.4 million for Q4 2025.

  • Quarterly results put Revenue at $76.4 million for Q4 2025, up 11.94% from a year ago — trailing twelve months through Dec 2025 was $308.1 million (up 37.22% YoY), and the annual figure for FY2025 was $308.1 million, up 37.22%.
  • Revenue for Q4 2025 was $76.4 million at PROCEPT BioRobotics, down from $83.3 million in the prior quarter.
  • Over the last five years, Revenue for PRCT hit a ceiling of $83.3 million in Q3 2025 and a floor of $7.2 million in Q1 2021.
  • Median Revenue over the past 5 years was $34.1 million (2023), compared with a mean of $38.9 million.
  • Biggest five-year swings in Revenue: surged 311.39% in 2021 and later rose 11.94% in 2025.
  • PROCEPT BioRobotics' Revenue stood at $10.1 million in 2021, then soared by 134.53% to $23.8 million in 2022, then surged by 83.29% to $43.6 million in 2023, then skyrocketed by 56.57% to $68.2 million in 2024, then rose by 11.94% to $76.4 million in 2025.
  • The last three reported values for Revenue were $76.4 million (Q4 2025), $83.3 million (Q3 2025), and $79.2 million (Q2 2025) per Business Quant data.